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INTRODUCTION
Tumor promoting agents are substances, which although noncarcinogenic themselves, cause tumor formation when applied repeatedly to mouse skin that has been previously treated with a subthreshold dose of a carcinogen. The most potent promoters in the mouse skin system are esters of the tetracyclic diterpene phorbol (1, 2) . The phorbol esters, in vitro, cause a variety of biological responses in many different cell types, including normal and leukemic blood cells (3) (4) (5) (6) . These include stimulation of hydrogen peroxide (H202) and superoxide anion (O°) production by polymorphonuclear leukocytes (PMN)' and monocytes (7) (8) (9) , aggregation and serotonin release by platelets (10, 11) , and mitogenesis in lymphocytes (12, 13) .
The phorbol esters bind in a specific, saturable, reversible fashion to a variety of cells and cell particulate fractions (14) (15) (16) (17) (14) and the production of interleukin 2 by lymphocytes (17) . Likewise, the binding affinities of the phorbol esters seem to parallel their tumor-promoting potencies in the mouse skin model (14) (15) (16) (17) (18) . It thus appears that these substances initiate their effects by binding to a specific cellular receptor.
In this study, using [20-3H] Hydrogen peroxide production. This assay was done in 96 chamber microtitre plates (Microtest II, No. 3040, Falcon Labware, Div. Becton-Dickinson & Co., Oxnard, CA) using a modification of a described method (23) . 1-2 X 105 monocytes or PMN were incubated in a total volume of 0.2 ml assay buffer containing 1 mg/ml glucose, 19 U/ml horseradish peroxidase, and 2 g/liter phenol red plus varying concentrations of potential stimulants for H202 release for 1 h at 37°C. The plates were then read using a Multiskan automatic eight-channel photometer (Flow Laboratories, Inc.) at 600 nm after alkalinization with 0.01 ml 1 N NaOH. H202 production was calculated by construction of a standard curve with exogenous H202.
Thymidine incorporation. Lymphocytes (3-5 X Comparable to the rate of association of the ligand, the rate of dissociation of cell-associated radioactivity, following the addition of excess unlabeled PDBu, was rapid at 230C, with <10% of the initial radioactivity remaining after 15 min (Fig. 2) Fig. 3 . Scatchard analysis of the binding data revealed linear curves for all of these blood cells suggesting the presence of one class of binding site in each case (Fig. 4) Fig. 7 , this was not the case in other comparable experiments and in experiments using mouse peritoneal macrophages (data not shown).
PDBu stimulated the release of [3H]5HT from platelets in a dose-dependent fashion (Fig. 8) release. DISCUSSION Recent studies support the hypothesis that the primary interaction of the phorbol esters is with specific binding sites on the cell surface, and that they may mediate at least some of their pleiotypic cellular effects via these receptors (14) (15) (16) (17) (18) . In the present report, using [3H]PDBu as a ligand, we have provided evidence that normal human blood lymphocytes, monocytes, PMN1, and platelets have specific receptors for [3H]PDBu and the related phorbol esters, while erythrocytes do not. In addition, we demonstrated the close correlation between the affinities of the phorbol esters for these receptors and their ability to evoke the biological responses of H202 generation by PMN replicates, and the SEM for the triplicates was <5%. All potential inhibitors were tested simultaneously using all three blood cell types obtained from the same donor. Similar results were obtained in three separate experiments. K, (Table II) were calculated as described (26) .
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FIGURE 6 Tritiated thymidine incorporation by lymphocytes cultured with phorbol-related compounds in the ab- 
